A detailed history of Advisor Group Holdings, Inc. transactions in Immutep LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 170 shares of IMMP stock, worth $336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 38 347.37%
Holding current value
$336
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.77 - $2.64 $233 - $348
132 Added 347.37%
170 $0
Q2 2024

Aug 13, 2024

BUY
$1.87 - $3.23 $71 - $122
38 New
38 $0
Q4 2023

Feb 12, 2024

SELL
$1.76 - $2.49 $3,520 - $4,980
-2,000 Reduced 97.32%
55 $0
Q3 2023

Nov 13, 2023

BUY
$1.75 - $2.37 $3,500 - $4,740
2,000 Added 3636.36%
2,055 $3,000
Q2 2023

Aug 10, 2023

BUY
$1.54 - $2.62 $84 - $144
55 New
55 $0

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $172M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.